QNASL (Teva Respiratory, LLC)
Welcome to the PulseAid listing for the QNASL drug offered from Teva Respiratory, LLC. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Respiratory, LLC |
| NON-PROPRIETARY NAME: | Beclomethasone Dipropionate |
| SUBSTANCE NAME: | BECLOMETHASONE DIPROPIONATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| ROUTE: | NASAL |
| DOSAGE FORM: | AEROSOL, METERED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-02-01 |
| END MARKETING DATE: | 0000-00-00 |
QNASL HUMAN PRESCRIPTION DRUG Details:
| Item Description | QNASL from Teva Respiratory, LLC |
| LABELER NAME: | Teva Respiratory, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40(ug/1) |
| START MARKETING DATE: | 2015-02-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59310-206_d6be2b23-e7a9-41d1-8c71-ea12812ccb07 |
| PRODUCT NDC: | 59310-206 |
| APPLICATION NUMBER: | NDA202813 |
Other BECLOMETHASONE DIPROPIONATE Pharmaceutical Manufacturers / Labelers:
